Published in Rev Esp Enferm Dig on May 01, 1994
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Improving drug therapy for patients with asthma--part 1: Patient outcomes. J Am Pharm Assoc (Wash) (2001) 1.82
Improving drug therapy for patients with asthma-part 2: Use of antiasthma medications. J Am Pharm Assoc (Wash) (2001) 1.52
[Improving communication between levels of health care: direct referral of patients to a one-stop service for major outpatient surgery]. Aten Primaria (2005) 1.44
Hazard potential ranking of hazardous waste landfill sites and risk of congenital anomalies. Occup Environ Med (2002) 1.43
Optimal primer selection for clonality assessment by polymerase chain reaction analysis: I. Low grade B-cell lymphoproliferative disorders of nonfollicular center cell type. Hum Pathol (1994) 1.39
Optimal primer selection for clonality assessment by polymerase chain reaction analysis: II. Follicular lymphomas. Hum Pathol (1994) 1.33
Hysterectomy in a Danish cohort. Prevalence, incidence and socio-demographic characteristics. Acta Obstet Gynecol Scand (1996) 1.18
Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes. Diabetologia (2005) 1.16
Incisional hernias after laparoscopic vs open cholecystectomy. Surg Endosc (1999) 1.07
Goitre prevalence and thyroid abnormalities at ultrasonography: a comparative epidemiological study in two regions with slightly different iodine status. Clin Endocrinol (Oxf) (2000) 1.01
The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin Endocrinol (Oxf) (1999) 0.93
Absence of fibronectin and presence of plasminogen activator in both normal and malignant human mammary epithelial cells in culture. J Cell Biol (1980) 0.93
Changes in hemostasis after laparoscopic cholecystectomy. Surg Endosc (1999) 0.93
Growth of normal and malignant human mammary epithelial cells in culture. J Natl Cancer Inst (1979) 0.92
Effectively controlling strongyloidiasis. Parasitol Today (1996) 0.91
Specificity of T and B lymphocytes for myeloma protein 315. Eur J Immunol (1977) 0.88
Costs and complications of hospitalizations for children with cerebral palsy. Pediatr Rehabil (2005) 0.83
Standard polymerase chain reaction analysis does not detect t(14;18) in reactive lymphoid hyperplasia. Arch Pathol Lab Med (1994) 0.83
Primers frequently used for detecting the t(14;18) major breakpoint also amplify Epstein-Barr viral DNA. Diagn Mol Pathol (1994) 0.80
Influence of the substrate's hydrophilicity on the in vitro Schwann cells viability. J Biomed Mater Res A (2007) 0.79
Production of BALB/c anti-idiotypic antibodies against the BALB/c myeloma protein 315 does not require an intact ligand-binding site. Scand J Immunol (1977) 0.79
[Carcinoma in a long-standing Zenker's diverticulum]. Rev Esp Enferm Dig (1994) 0.78
Electrospun adherent-antiadherent bilayered membranes based on cross-linked hyaluronic acid for advanced tissue engineering applications. Mater Sci Eng C Mater Biol Appl (2013) 0.78
Fibrinolytic activity in laparoscopic cholecystectomy. J Laparoendosc Adv Surg Tech A (1998) 0.77
Estrogen use and gallstone disease. Am J Public Health (1989) 0.75
[Muscular tumors of the stomach]. Rev Esp Enferm Apar Dig (1980) 0.75
[Bacterial translocation in intestinal transplant]. Cir Pediatr (1999) 0.75
Free flow electrophoresis of isolated secretory granules from bovine neurohypophyses. Experientia (1972) 0.75
[Etiopathogenetic factors in postoperative gastritis caused by alkaline reflux. I. Clinical aspects]. Rev Clin Esp (1984) 0.75
Roux-en-Y syndrome after surgical treatment of alkaline reflux gastritis. Rev Esp Enferm Dig (1999) 0.75
[Etiopathogenic factors in postoperative gastritis caused by alkaline reflux. II. Experimental aspects]. Rev Clin Esp (1984) 0.75
[Antiaggregant drugs in traumatic shock lung. Experimental study]. Rev Clin Esp (1984) 0.75
[Surgical treatment of cancer of the cardia]. Rev Esp Enferm Apar Dig (1986) 0.75
[Acute cholecystitis: an evaluation of the factors that determine the start of surgical treatment]. Rev Esp Enferm Dig (1993) 0.75
New semi-biodegradable materials from semi-interpenetrated networks of poly(ϵ-caprolactone) and poly(ethyl acrylate). Macromol Biosci (2014) 0.75
[Primary retroperitoneal cysts of enteric origin]. Rev Esp Enferm Apar Dig (1978) 0.75
[Determination of basal and stimulated blood gastrin in duodenal ulcer]. Rev Esp Enferm Dig (1992) 0.75
[Mesenteric cysts. Report of 3 cases]. Rev Esp Enferm Apar Dig (1983) 0.75
[Congenital membranous mucosa of the gastric antrum]. Rev Esp Enferm Apar Dig (1978) 0.75
[Biliary ileus]. Rev Esp Enferm Apar Dig (1981) 0.75
[Transomental hernia, An unusual form of internal hernia]. Rev Esp Enferm Apar Dig (1979) 0.75
[Distomatosis caused by Fasciola hepatica. Study of an epidemic outbreak]. Rev Esp Enferm Apar Dig (1988) 0.75
[Anatomopathologic changes in the distal esophagus following proximal gastric vagotomy. Experimental study]. Rev Esp Enferm Dig (1995) 0.75
[Benign epithelial tumors of the stomach]. Rev Esp Enferm Apar Dig (1980) 0.75
[Blood gastrin changes in the late postoperative period after proximal gastric vagotomy]. Rev Esp Enferm Dig (1994) 0.75
Operating table controlling water balance and temperature of cats. IEEE Trans Biomed Eng (1972) 0.75
[Changes in coagulation and their relation to pulmonary lesions in endotoxic shock. Experimental study]. Rev Clin Esp (1983) 0.75
[Functional and morphodynamical study of intestinal villi]. Rev Esp Enferm Apar Dig (1977) 0.75
[Etiopathogenic factors in postoperative gastritis caused by alkaline reflux. III. Mechanism of action]. Rev Clin Esp (1984) 0.75
[Our experience with the use of vagotomy in the treatment of duodenal ulcer. Preliminary results]. Rev Esp Enferm Apar Dig (1978) 0.75
[Terminal aortic embolism as an unusual form of presentation of apical hypertrophy]. Rev Clin Esp (1990) 0.75
[Risk factors of peptic ulcer hemorrhage]. Rev Esp Enferm Dig (1995) 0.75
Laboratory evaluation of the effect of prophylaxis for thromboembolism with fractionated heparin in patients undergoing laparoscopic cholecystectomy. Rev Esp Enferm Dig (2000) 0.75